LGC acquires Rapid Genomics, bolstering its position in the application of NGS for high-throughput genotyping market in AgBio

News (ZH) - Rapid Genomics is a leading company in genotyping applications via Next-Generation Sequencing

LGC’s SARS-CoV-2 ultra-high throughput End-Point PCR test EUA authorised by FDA

News (ZH) - Nexar™-based workflow enables simple, scalable, and cost-effective COVID-19 testing

LGC’s new state-of-the-art site in Oxford will deliver critical diagnostics solutions and research

News (ZH) - Facility will serve as home of The Native Antigen Company and an advanced workflow applications laboratory for LGC Biosearch Technologies